Randomized study of docetaxcel plus cisplatin versus gecitabine plus cisplatin in treatment of advanced non-small cell lung caner

Haiping SONG; Songping WANG; Cuiping SUN; Wensheng QIU; Jun LIANG

Randomized study of docetaxcel plus cisplatin versus gecitabine plus cisplatin in treatment of advanced non-small cell lung caner / 中国癌症杂志

Haiping SONG; Songping WANG; Cuiping SUN; Wensheng QIU; Jun LIANG.

China Oncology ; (12)2006.

Article in Chinese | WPRIM (Western Pacific) | ID: wpr-546495

Responsible library: WPRO

ABSTRACT

ABSTRACT

0.05). The mainly side-effects were myelosuppression, nausea, and vomiting.

Conclusions:

Docetaxel/cisplatin and gemcitabine/cisplatin regimens were well toleranced in advanced NSCLC patients with long term survival.

non-small cell lung cancer; chemotherapy; docetaxel; gemcitabine; cisplatin

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Database: WPRIM (Western Pacific) Type of study: Controlled clinical trial Language: Chinese Journal: China Oncology Year: 2006 Document type: Article

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Database: WPRIM (Western Pacific) Type of study: Controlled clinical trial Language: Chinese Journal: China Oncology Year: 2006 Document type: Article